Literature DB >> 15465069

Social support as a buffer in the relationship between treatment for depression and T-cell production of interferon gamma in patients with multiple sclerosis.

David C Mohr1, Claude Genain.   

Abstract

OBJECTIVE: This study examined the buffering effects of social support on the relationship between depression and autoaggressive immune function in multiple sclerosis (MS).
METHODS: Fourteen participants with comorbid diagnoses of MS and major depressive disorder received 16 weeks of psychotherapy or antidepressant medications. Depression and T-cell production of interferon-gamma (IFN-gamma), a lynchpin in MS pathogenesis, were assessed at baseline and posttreatment. Social support was assessed at baseline.
RESULTS: Both depression and T-cell production of IFN-gamma were significantly reduced over the 16 weeks of treatment. There was a significant interaction between change in depression, change in IFN-gamma, and social support (R(2)=.26, P=.03) such that social support served as a buffer.
CONCLUSION: These results support the hypothesis that social support buffers the effects of change in depression on IFN-gamma production. However, these findings should be viewed as preliminary due to the small sample size and the absence of a control condition.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15465069     DOI: 10.1016/S0022-3999(03)00601-9

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  11 in total

1.  Effects of depression and social support on comprehension and recall of informed consent information among Parkinson disease patients and their caregivers.

Authors:  Ellen J Teng; Nancy J Petersen; Christine Hartman; Ellen Matthiesen; Michael Kallen; Karon F Cook; Marvella E Ford
Journal:  Int J Psychiatry Med       Date:  2012       Impact factor: 1.210

Review 2.  Social buffering: relief from stress and anxiety.

Authors:  Takefumi Kikusui; James T Winslow; Yuji Mori
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-12-29       Impact factor: 6.237

Review 3.  Stress and multiple sclerosis.

Authors:  David C Mohr
Journal:  J Neurol       Date:  2007-05       Impact factor: 4.849

4.  Development and effectiveness of a psychoeducational wellness program for people with multiple sclerosis: description and outcomes.

Authors:  Kimberly Beckwith McGuire; Jelena Stojanovic-Radic; Lauren Strober; Nancy D Chiaravalloti; John DeLuca
Journal:  Int J MS Care       Date:  2015 Jan-Feb

5.  Psychosocial Interventions and Immune System Function: A Systematic Review and Meta-analysis of Randomized Clinical Trials.

Authors:  Grant S Shields; Chandler M Spahr; George M Slavich
Journal:  JAMA Psychiatry       Date:  2020-10-01       Impact factor: 21.596

6.  Managing Neuropsychological Impairment in Multiple Sclerosis: Pilot Study on a Standardized Metacognitive Intervention.

Authors:  Jana Pöttgen; Stephanie Lau; Iris Penner; Christoph Heesen; Steffen Moritz
Journal:  Int J MS Care       Date:  2015 May-Jun

7.  A randomized trial of stress management for the prevention of new brain lesions in MS.

Authors:  David C Mohr; Jesus Lovera; Ted Brown; Bruce Cohen; Thomas Neylan; Roland Henry; Juned Siddique; Ling Jin; David Daikh; Daniel Pelletier
Journal:  Neurology       Date:  2012-07-11       Impact factor: 9.910

8.  The effect of telephone-administered cognitive-behavioral therapy on quality of life among patients with multiple sclerosis.

Authors:  David Cosio; Ling Jin; Juned Siddique; David C Mohr
Journal:  Ann Behav Med       Date:  2011-04

9.  Hostility and helper T-cells in patients with bulimia nervosa.

Authors:  F J Vaz-Leal; L Rodríguez-Santos; M J Melero; M I Ramos; M Monge; B López-Vinuesa
Journal:  Eat Weight Disord       Date:  2007-06       Impact factor: 4.652

Review 10.  Depression in Multiple Sclerosis: Epidemiology, Aetiology, Diagnosis and Treatment.

Authors:  Claudio Solaro; Giulia Gamberini; Fabio Giuseppe Masuccio
Journal:  CNS Drugs       Date:  2018-02       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.